London, 2 April 2019, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is proud to have supported Cambridge Innovation Capital plc (CIC), the venture capital investor focused on IP-rich technology and life science businesses in the Cambridge ecosystem, on its £150 million fundraise.
The financing was supported by a geographically diverse range of new institutional and strategic investors, with the University of Cambridge and Cambridge University Endowment Fund contributing the cornerstone investment which brings the total amount of capital raised by CIC to date to £275 million. The financing is one of the largest private financing rounds in Europe this year and more than doubles the financial resources available to CIC. The funds will be used to support CIC’s current portfolio of 25 companies and enable investment in new opportunities arising from both the University of Cambridge and the wider Cambridge ecosystem.
“CIC has gone from strength to strength since its inception in 2013 and is now the key healthcare and tech investor within the Cambridge ecosystem. Consilium is proud to work closely with CIC and was pleased to advise on this successful fundraise, one of the largest private rounds in Europe this year. We look forward to continuing to work with the CIC team as it deploys this capital and continues to grow.”
Mary-Jane Elliott
Managing Partner of Consilium Strategic Communications
To view CIC’s announcement please visit https://www.cicplc.co.uk/.
